Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Uchida

Showing results (11-20 of 508) with videos related to

Pageof 51
Sort By:
The International Journal of Neuropsychopharmacology|June 22, 2012
Critical review of antipsychotic polypharmacy in the treatment of schizophreniaW Wolfgang Fleischhacker, Hiroyuki Uchida
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 12, 2009
Dosing of antipsychotics in schizophrenia across the life-spectrumHiroyuki Uchida, David C Mamo
The Keio Journal of Medicine|March 14, 2012
Mental health and psychosocial support after the Great East Japan EarthquakeYutaka Kato, Hiroyuki Uchida, Masaru Mimura
The Journal of Physical Chemistry. B|October 27, 2006
Temperature dependence of CO-tolerant hydrogen oxidation reaction activity at Pt, Pt-Co, and Pt-Ru electrodesHiroyuki Uchida, Kenji Izumi, Masahiro Watanabe
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|September 27, 2013
[The effects of age, period, and birth cohorts on the rates of overweight and underweight students in 1977-2006 and a prediction of the rates in 2007-2016]Youichi Odagiri, Hiroyuki Uchida, Katsuhiro Koyama
Gut|May 27, 2018
Long-term proton pump inhibitor use after <i>Helicobacter pylori</i> eradication may create a gastric environment for <i>N</i>-nitrosamine formation and gastric cancer developmentJun Kobayashi, Hiroyuki Uchida, Junta Ito
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|October 31, 2015
[A Proposal for Natural Resilience Theory in Psychopharmacotherapy: To Deter High-dose Antipsychotic Polypharmacy]Gohei Yagi, Takefumi Suzuki, Hiroyuki Uchida
Pharmacopsychiatry|March 5, 2026
Artificial Intelligence in Drug Discovery and Development: Raising Quality per DecisionShota Furukawa, Hiroyuki Uchida, Taishiro Kishimoto
Current Psychiatry Reports|February 18, 2011
A tipping point in drug dosing in late-life schizophreniaTakashi Tsuboi, Takefumi Suzuki, Hiroyuki Uchida
Journal of Clinical Psychopharmacology|August 17, 2018
Psychopharmacology in Japan: An Overview and Recent TopicsKazunari Yoshida, Takefumi Suzuki, Hiroyuki Uchida
Pageof 51

Showing results (11-20 of 508) with videos related to

Sort By:
Pageof 51
The International Journal of Neuropsychopharmacology|June 22, 2012
Critical review of antipsychotic polypharmacy in the treatment of schizophreniaW Wolfgang Fleischhacker, Hiroyuki Uchida
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 12, 2009
Dosing of antipsychotics in schizophrenia across the life-spectrumHiroyuki Uchida, David C Mamo
The Keio Journal of Medicine|March 14, 2012
Mental health and psychosocial support after the Great East Japan EarthquakeYutaka Kato, Hiroyuki Uchida, Masaru Mimura
The Journal of Physical Chemistry. B|October 27, 2006
Temperature dependence of CO-tolerant hydrogen oxidation reaction activity at Pt, Pt-Co, and Pt-Ru electrodesHiroyuki Uchida, Kenji Izumi, Masahiro Watanabe
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|September 27, 2013
[The effects of age, period, and birth cohorts on the rates of overweight and underweight students in 1977-2006 and a prediction of the rates in 2007-2016]Youichi Odagiri, Hiroyuki Uchida, Katsuhiro Koyama
Gut|May 27, 2018
Long-term proton pump inhibitor use after <i>Helicobacter pylori</i> eradication may create a gastric environment for <i>N</i>-nitrosamine formation and gastric cancer developmentJun Kobayashi, Hiroyuki Uchida, Junta Ito
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|October 31, 2015
[A Proposal for Natural Resilience Theory in Psychopharmacotherapy: To Deter High-dose Antipsychotic Polypharmacy]Gohei Yagi, Takefumi Suzuki, Hiroyuki Uchida
Pharmacopsychiatry|March 5, 2026
Artificial Intelligence in Drug Discovery and Development: Raising Quality per DecisionShota Furukawa, Hiroyuki Uchida, Taishiro Kishimoto
Current Psychiatry Reports|February 18, 2011
A tipping point in drug dosing in late-life schizophreniaTakashi Tsuboi, Takefumi Suzuki, Hiroyuki Uchida
Journal of Clinical Psychopharmacology|August 17, 2018
Psychopharmacology in Japan: An Overview and Recent TopicsKazunari Yoshida, Takefumi Suzuki, Hiroyuki Uchida
Pageof 51